Neuralink, a neuro-implant company owned by Elon Musk has received an approval from US Food and Drug Administration (FDA) to conduct first human trial for its brain implant.
Tag Archives: FDA
Alzheimer’s disease: treatments at last
On the 6th of January 2023 the Food and Drug Administration (FDA) approved Lecanemab-irmb through the accelerated approval pathway to treat Alzheimer’s disease. There has been rigorous efforts to combat this dreaded disease. Lecanemab is a second drug now approved for the treatment of Alzheimer’s disease. The first, named aducanumab, was earlier approved by FDAContinue reading “Alzheimer’s disease: treatments at last”
ASVEK Science & Tech 